6.17
+0.33
+(5.65%)
At close: April 17 at 4:00:02 PM EDT
6.17
0.00
(0.00%)
After hours: April 17 at 4:05:08 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-68,717
-68,717
-192,977
-270,430
-220,522
Investing Cash Flow
8,624
8,624
123,866
202,956
22,258
Financing Cash Flow
59,282
59,282
2,010
53,084
103,944
End Cash Position
25,176
25,176
25,987
93,088
107,478
Income Tax Paid Supplemental Data
24
24
2
19
15
Interest Paid Supplemental Data
685
685
447
335
32
Capital Expenditure
-246
-246
-1,223
-4,193
-10,580
Issuance of Capital Stock
59,951
59,951
2,136
21,891
98,697
Repayment of Debt
-892
-892
-947
-518
-254
Free Cash Flow
-68,963
-68,963
-194,200
-274,623
-231,102
12/31/2021 - 10/16/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABEO Abeona Therapeutics Inc.
4.8400
-0.21%
FDMT 4D Molecular Therapeutics, Inc.
3.0600
+5.15%
MIST Milestone Pharmaceuticals Inc.
0.8889
+8.80%
MGNX MacroGenics, Inc.
1.2600
+6.78%
RGNX REGENXBIO Inc.
5.94
-3.57%
ANNX Annexon, Inc.
1.4600
+2.10%
GRCE Grace Therapeutics, Inc.
2.0900
+2.96%
REPL Replimune Group, Inc.
8.00
+4.78%
ALDX Aldeyra Therapeutics, Inc.
2.1900
+8.96%
WVE Wave Life Sciences Ltd.
5.92
+1.37%